MASIMO CORPORATION (NASDAQ:MASI) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

ME Staff 8-k
-
0

MASIMO CORPORATION (NASDAQ:MASI) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item 5.02….Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.

The information set forth below under Item 5.07 of this Current
Report on Form 8-K is hereby incorporated by reference into this
Item 5.02.
Item 5.07.
Submission of Matters to a Vote of Security Holders.
Masimo Corporation (the Company) held its 2017 Annual Meeting of
Stockholders on June 1, 2017>(the Meeting). At the Meeting, a
total of 46,435,240 shares, or 90.79% of the Companys common
stock issued and outstanding as of the record date, were
represented in person or by proxy.
At the Meeting, the Companys stockholders considered six
proposals, each of which is described in more detail in the
Companys definitive proxy statement filed with the Securities and
Exchange Commission (SEC) on April 11, 2017, as supplemented by
the supplements thereto filed with the SEC on May 24, 2017 and
May 26, 2017.
Set forth below is a brief description of each matter voted upon
at the Meeting and the voting results with respect to each
matter.
Proposal No. 1:>To elect the following nominees as Class I
directors to serve until the Companys 2020 Annual Meeting of
Stockholders.

Nominee
For
Against
Abstentions
Broker Non-Votes
Dr. Steven J. Barker
40,324,787
1,712,812
16,315
4,381,326
Sanford Fitch
41,668,707
367,547
17,660
4,381,326
Proposal No. 2:>To ratify the selection of Grant Thornton LLP
as the Companys independent registered public accounting firm for
the Companys fiscal year ending December 30, 2017.

For
Against
Abstentions
46,229,974
155,419
49,847
Proposal No. 3: To vote on an advisory resolution to approve
Named Executive Officer Compensation.

For
Against
Abstentions
Broker Non-Votes
31,396,473
10,463,957
193,484
4,381,326
Proposal No. 4: To vote on an advisory resolution on the
frequency of future advisory resolutions to approve Named
Executive Compensation.
Every Year
(an annual vote)
Every Other Year (a biennial vote)
Every Three Years (a triennial vote)
Abstentions
Broker Non-Votes
34,110,634
50,046
7,787,051
106,183
4,381,326
Proposal No. 5: To vote on the approval of the Companys 2017
Equity Incentive Plan.

For
Against
Abstentions
Broker Non-Votes
25,344,555
16,675,097
34,262
4,381,326
Proposal No. 6: To vote on the approval of the Companys Executive
Bonus Incentive Plan.

For
Against
Abstentions
Broker Non-Votes
41,531,637
439,362
82,915
4,381,326


About MASIMO CORPORATION (NASDAQ:MASI)

Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. The Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. It has also developed the Patient SafetyNet remote patient surveillance monitoring system, which allows over 200 patients to be monitored simultaneously and remotely through a personal computer (PC)-based viewing station or by care providers through their voice-over-Internet Protocol (IP) phones.